PTPRC and melanoma: ATAC-seq of CD45-negative sorted melanoma cells also showed that 45.9% of open chromatin regions acquired by an IFN-treated, ICB-resistant melanoma cell line overlapped with acquired open chromatin regions in samples derived from patients with relapsing tumours that initially responded well to immunotherapy, suggesting a common epigenetic mechanism [6].